Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (21222)	4/23/1999 2:38:00 AM
From: VLAD	Read Replies (2) \| Respond to of 23519

****EVEN BETTER(SORT OF) NEWS*** This I just heard from a reliable long time source: Vivus was fairly sure that they had a deal in the bag for a domestic partner with AZ. The main person Vivus was negotiating with at Astra before the merger had given the green light for the deal. Then this merger crap creates some undesired turmoil. Evidently the higher up of the Astra negotiator is a Zeneca man. And due to egos and a still in process jockeying for power struggle the Zeneca man decided to flex his ego and not give approval for the deal. Can't blame Lee for that. I hear that Vivus is not going to have its chain pulled by this jerk from Zeneca. They still would like the deal but they are not going to hold their breath. So in the mean time Vivus is focusing on negotiations with the number 2 large pharma interest on their list. If the Zeneca jerk would give the green flag then Vivus could announce a deal tomorrow. If this jerk want to play hard ball so be it. Then Vivus moves on and hopefully works out a reasonable deal with the other pharma. Point is that there always was a domestic partner lined up (ie Astra) but the merger with Zeneca stunk it all up. However this doesn't mean that the present hurdle can't be crossed in the very near future. Oh and that extra money that we were wondering about after the cc. It all came from Astra/Zeneca. Apparently in their contract Astra was obligated to front a certain amount of money even if they were not ordering product that Vivus could have to guarantee operations income and that would be credited to Astra when future product orders are made. It was money in the bank for Vivus and has no effects on future earnings since it was not calculated into present earnings but just the bottom line. More to come. VLAD

To: VLAD who wrote (21222)	4/23/1999 7:07:00 AM
From: Frostman	Respond to of 23519

"From what the info I have now....through mid February in the United States there was almost 9M Viagra prescriptions written to 4M men with 235 associated deaths reported . This is one death for every 17,000 men who tried Viagra." If that figure is remotely accurate... My region has approx. 100,000 men 55 plus (target group for ED meds), if they all got scripts tonight, there is a chance that the Sunday top newspaper, radio, and TV story would lead with something like... 'Deaths of 5 Area Men Over the Weekend Linked to Sex Drug' Man, is it even possible that more than five in every 100,000 guys compromised by an existing health/medical condition such that we're talking lethal results? I realize that my example is unrealistic for many reasons, but when I expressed the offered numbers in terms of my own community, the impact was chilling. I know what the odds are of winning the lottery, often millions to one, and I still play because there is a chance. If the odds of dying through the ingestion of a prescription drug were issued at the pharmacy... Just Musing, Frostman